Clinical Trial Update

The Dynamic Coronary Roadmap (DCR) and the DCR4Contrast Multicenter, International, Randomized, Controlled Trial

John C. Messenger, MD, FACC, FSCAI

Director, Interventional Cardiology; Clinical Director, UCH Heart and Vascular Center, University of Colorado Hospital; Professor of Medicine—Cardiology, University of Colorado School of Medicine

05/19/2023

On behalf of the DCR4Contrast Trial Investigators, Dr. Messenger shares a real-world evaluation of the feasibility and quality of PCI guidance using Dynamic Coronary Roadmap (Philips) in a secondary analysis of the DCR4Contrast multicenter, international, randomized, controlled trial.

Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions Newsroom

The Dynamic Coronary Roadmap (DCR) and the DCR4Contrast Multicenter, International, Randomized, Controlled Trial

Subscriber

Job Board

Specialties

Events

Year Round Education

HMP Global Products